Concepedia

Lisa Connery

LC

Statistics

Publications

7

Citations

4K

H-Index

7

Active since

1999

Affiliations

Eli Lilly (United States)(Current)

Alliance for Multispecialty Research (United States)

Velocity Clinical Research (United States)

York University

McMaster University

Lisa Connery is an author at Eli Lilly (United States) specializing in diabetes, medicine, and pharmacology.

Top concepts

Publications per year

1999–2025

7

Publications

7

Tirzepatide Once Weekly for the Treatment of Obesity

Ania M. Jastreboff, Louis J. Aronne, Nadia N. Ahmad et al. · New England Journal of Medicine · 2022 · 2.7K citations · Full text

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

, , +9

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

Sean Wharton, Thomas Blevins, Lisa Connery et al. · New England Journal of Medicine · 2023 · 378 citations

Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial

Ofri Mosenzon, Thalia Marie Blicher, Signe Rosenlund et al. · The Lancet Diabetes & Endocrinology · 2019 · 317 citations · Full text

, , +11

Cardiovascular collapse associated with extreme iatrogenic PEEPi in patients with obstructive airways disease

Lisa Connery, M J Deignan, M W Gujer et al. · British Journal of Anaesthesia · 1999 · 18 citations · Full text

1–5 of 7